Thomas J. Schall
2013
In 2013, Thomas J. Schall earned a total compensation of $2.3M as President and Chief Executive Officer at ChemoCentryx, a 64% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $210,375 |
|---|---|
| Option Awards | $1,594,824 |
| Salary | $510,000 |
| Other | $690 |
| Total | $2,315,889 |
Schall received $1.6M in option awards, accounting for 69% of the total pay in 2013.
Schall also received $210.4K in non-equity incentive plan, $510K in salary and $690 in other compensation.
Rankings
In 2013, Thomas J. Schall's compensation ranked 3,383rd out of 12,286 executives tracked by ExecPay. In other words, Schall earned more than 72.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,383 out of 12,286 | 73rd |
Division Manufacturing | 1,144 out of 4,612 | 75th |
Major group Chemicals And Allied Products | 306 out of 1,462 | 79th |
Industry group Drugs | 210 out of 1,156 | 82nd |
Industry Pharmaceutical Preparations | 174 out of 890 | 80th |
Source: SEC filing on April 9, 2015.
Schall's colleagues
We found two more compensation records of executives who worked with Thomas J. Schall at ChemoCentryx in 2013.